Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 7 Neoplasms 2 Leiomyosarcoma 2 Wilms Tumor 1 Unspecified Childhood Solid Tumor, Protocol Specific 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Neuroblastoma 1 Neoplasms, Connective and Soft Tissue 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Liver Diseases 1 Liposarcoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hepatic Insufficiency 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Bone Neoplasms 1

Interventions

Cyclophosphamide 3 pembrolizumab 2 Radiotherapy 2 Radiation 2 Gemcitabine 2 Etoposide 2 Doxorubicin 2 Cryotherapy 2 Cryosurgery 2 tocilizumab 1 selinexor 1 robatumumab 1 poly ICLC 1 olaparib 1 montanide ISA 51 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 flt3 ligand protein 1 eltrombopag 1 cc-486 1 Vincristine 1 Trabectedin 1 Temozolomide 1 Radiotherapy, Intensity-Modulated 1 Leukapheresis 1 Irinotecan 1 Interleukin-2 1 Injections 1 Imiquimod 1 Ifosfamide 1 Denosumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Bone Neoplasms × Trabectedin × Clear all

NCT02398058 2021-04-14

TOMAS

Italian Sarcoma Group

Phase 1 Completed

Bone Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡